Research Article

Cost-Effectiveness Of Using Haematopoetic Growth Factor In Consolidation Therapy Of Patients With Acute Myeloid Leukemia

10.1501/Tipfak_0000000843

  • Pınar Tarkun
  • Elif Birtaș Ateșoğlu
  • Abdullah Hacıhanefioğlu
  • Özgür Mehtap
  • Emel Gönüllü

Received Date: 06.03.2012 Accepted Date: 26.02.2014 J Ankara Univ Fac Med 2013;66(2):65-70

Keywords: Haematopoetic growth factor, AML, cost-effectiveness